Literature DB >> 18800147

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.

E Willems, F Baron, E Baudoux, N Wanten, L Seidel, J-F Vanbellinghen, C Herens, A Gothot, P Frère, C Bonnet, K Hafraoui, G Vanstraelen, G Fillet, Y Beguin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18800147     DOI： 10.1038/leu.2008.248

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.

Authors:  Emilie Castermans; Muriel Hannon; Jacques Dutrieux; Stéphanie Humblet-Baron; Laurence Seidel; Rémi Cheynier; Evelyne Willems; André Gothot; Jean-François Vanbellinghen; Vincent Geenen; Brenda M Sandmaier; Rainer Storb; Yves Beguin; Frédéric Baron
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

2.  Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease.

Authors:  Laetitia Boucault; Maria-Dolores Lopez Robles; Allan Thiolat; Séverine Bézie; Michael Schmueck-Henneresse; Cécile Braudeau; Nadège Vimond; Antoine Freuchet; Elodie Autrusseau; Frédéric Charlotte; Rabah Redjoul; Florence Beckerich; Mathieu Leclerc; Eliane Piaggio; Regis Josien; Hans-Dieter Volk; Sébastien Maury; José L Cohen; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2020-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.